May 2004
Volume 45, Issue 13
ARVO Annual Meeting Abstract  |   May 2004
Author Affiliations & Notes
  • S. Katragadda
    Pharmaceutical Sciences, University of Missouri–Kansas City, Kansas City, MO
  • B.S. Anand
    Pharmaceutical Sciences, University of Missouri–Kansas City, Kansas City, MO
  • A.K. Mitra
    Pharmaceutical Sciences, University of Missouri–Kansas City, Kansas City, MO
  • Footnotes
    Commercial Relationships  S. Katragadda, None; B.S. Anand, None; A.K. Mitra, None.
  • Footnotes
    Support  EY09171
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5048. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Katragadda, B.S. Anand, A.K. Mitra; MechanismofCornealPermeationofAminoAcidEsterProdrugsofAcyclovir . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5048.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:The aim of this study was to explore the feasibility of utilizing amino acid transporters on the rabbit cornea for improved bioavailability of the antiviral agent, Acyclovir (ACV). Methods:The chemical hydrolysis, enzymatic hydrolysis in various ocular tissues and transport characteristics of water–soluble amino acid prodrugs of ACV, ã–Glutamate–ACV (EACV) and L–Tyrosine–ACV (YACV) were studied across freshly excised rabbit cornea. Results:EACV inhibited the uptake of [3H] L–Arg across rPCEC and also exhibited an appreciable half–life in cornea in comparison to YACV. The transport of EACV was found to be concentration, energy dependent and sodium dependent and independent of pH and also inhibited in presence of neutral amino acids, cationic amino acids, ornithine and BCH (specific inhibitor for L–type system). On the other hand YACV was not recognized by the amino acid transporters as it failed to inhibit the uptake of [3H] Arg and also its transport across cornea was not inhibited by arginine. YACV and EACV exhibited excellent antiviral activity against HSV–1 & 2 and VZV in comparison to ACV. Conclusion:Analyses of the pattern of inhibition of transport of EACV suggests the involvement of a single transport system namely B0,+. Design of amino acid prodrugs seems to be an attractive strategy to enhance the solubility of the otherwise poorly aqueous soluble compounds and also to afford a targeted and possibly enhanced delivery of the active drug.

Keywords: AIDS/HIV • ion transporters • anterior chamber 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.